Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Clinical blood biochemical analysis is a cornerstone of modern laboratory medicine, enabling quantitative measurement of enzymes, metabolites, electrolytes, proteins, and lipids in blood to evaluate organ function and guide clinical decision-making. This article provides a comprehensive technical overview of sample types, testing panels, analytical methods, and clinical applications of blood biochemistry testing.

Technical Overview

Clinical blood biochemical analysis refers to the in vitro quantitative determination of chemical constituents in blood specimens, including enzymes, metabolites, electrolytes, proteins, lipids, and trace elements, for the purpose of assessing organ function, screening for metabolic disorders, and monitoring disease progression and treatment response.

Modern blood biochemistry testing is performed on fully automated chemistry analyzers that integrate photometric detection systems, ion-selective electrode modules, reagent handling robotics, and intelligent sample management. Most photometric assays follow the Beer-Lambert law, measuring absorbance changes at characteristic wavelengths (typically 340, 405, 505, 546, and 600–700 nm) to calculate analyte concentrations through endpoint or kinetic (rate) reactions.

Analytical performance is governed by rigorous quality assurance systems, including calibration traceable to international reference materials, internal quality control procedures run at multiple decision levels, and external quality assessment programs compliant with ISO 15189 and CLSI standards. Key performance specifications include precision (coefficient of variation), accuracy, linear range, detection limit, and carryover rate.

Testing Samples

Serum

Serum is the most widely used specimen type for blood biochemistry analysis. Blood is collected into plain tubes or serum separator tubes containing a clot activator and gel, allowed to clot for 30 minutes at room temperature, and then centrifuged at 1,000–2,000 × g for 10 minutes. Serum is free of anticoagulant interference, making it suitable for the majority of biochemistry assays, including liver function, renal function, lipid, and enzyme tests.

Plasma

Plasma is obtained by centrifuging anticoagulated whole blood, commonly with lithium heparin, which is the preferred anticoagulant for clinical chemistry because it minimizes interference with most analytical methods. Plasma offers the advantage of immediate processing without waiting for clot formation, reducing turnaround time in urgent settings. EDTA plasma is suitable for specific applications but must not be used for potassium or calcium measurement, while citrate plasma dilutes analyte concentrations and requires correction factors.

Whole Blood

Whole blood specimens are used primarily for point-of-care testing, blood gas and electrolyte analysis, and rapid glucose measurement. Heparinized arterial or capillary whole blood is analyzed directly by portable or benchtop analyzers, enabling results within minutes for critical care, emergency medicine, and perioperative monitoring.

Regardless of specimen type, samples should be inspected for hemolysis, lipemia, and icterus, as these matrix interferences can significantly distort photometric measurements. Serum and plasma remain stable for most analytes at 2–8°C for 24–72 hours; prolonged storage requires freezing at -20°C or below.

Testing Items

Clinical blood biochemistry panels are organized by organ system and clinical purpose. Common panels include the following:

Liver Function Panel

  • Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) for hepatocellular injury assessment
  • Alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT) for cholestatic disease evaluation
  • Total and direct bilirubin for jaundice differentiation
  • Total protein, albumin, and the albumin-to-globulin ratio for synthetic function and nutritional status
  • Cholinesterase and prealbumin as sensitive markers of hepatic synthetic capacity

Renal Function Panel

  • Urea (BUN) and creatinine for glomerular filtration assessment
  • Estimated glomerular filtration rate (eGFR) calculated from creatinine, age, and sex
  • Uric acid for purine metabolism and gout evaluation
  • Cystatin C as a sensitive alternative filtration marker unaffected by muscle mass

Cardiac and Muscle Enzyme Panel

  • Creatine kinase (CK) and CK-MB for myocardial and skeletal muscle injury
  • Lactate dehydrogenase (LDH) and alpha-hydroxybutyrate dehydrogenase (α-HBDH) as supplementary injury markers
  • Myoglobin for early detection of muscle damage

Lipid Panel

  • Total cholesterol (TC) and triglycerides (TG)
  • High-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C)
  • Apolipoproteins A1 and B, and lipoprotein(a) for refined cardiovascular risk stratification

Metabolic Markers

  • Fasting blood glucose and postprandial glucose for diabetes diagnosis and monitoring
  • Glycated hemoglobin (HbA1c) reflecting 2–3 month average glycemic control, measured in EDTA whole blood
  • Lactate for tissue perfusion and metabolic acidosis evaluation

Electrolytes and Minerals

  • Sodium, potassium, and chloride maintaining osmotic and acid-base balance
  • Total and ionized calcium, phosphorus, and magnesium for bone and mineral metabolism
  • Iron, total iron-binding capacity, and ferritin for iron metabolism evaluation

Pancreatic and Digestive Enzymes

  • Alpha-amylase and lipase for acute pancreatitis diagnosis
  • Pepsinogen I and II as gastric mucosal function markers

Testing Methods

Photometric Endpoint and Kinetic Assays

Endpoint assays measure absorbance after the reaction reaches completion, suitable for substrates such as glucose, cholesterol, and uric acid. Kinetic (rate) assays monitor the change in absorbance per unit time during the initial reaction phase, which is the standard approach for enzyme activity measurement of ALT, AST, CK, and LDH, offering improved specificity and reduced interference.

Enzymatic Colorimetric Methods

Enzymatic methods employ coupled enzyme reaction systems, such as hexokinase or glucose oxidase for glucose, cholesterol oxidase for cholesterol, and urease for urea, generating colorimetric products proportional to analyte concentration. These methods demonstrate high specificity and are the reference approaches recommended by international guidelines.

Ion-Selective Electrode Technology

Electrolytes including sodium, potassium, chloride, and ionized calcium are measured by ion-selective electrodes in either direct (undiluted) or indirect (diluted) mode. Potentiometric detection provides rapid, precise results and is unaffected by sample color or turbidity.

Immunoturbidimetric Methods

Specific proteins such as apolipoproteins, immunoglobulins, C-reactive protein, and lipoprotein(a) are quantified by immunoturbidimetry or latex-enhanced immunoturbidimetry, in which antigen-antibody complexes increase solution turbidity in proportion to analyte concentration.

Dry Chemistry Technology

Dry chemistry systems use multilayer film slides impregnmented with dried reagents. A drop of sample is applied to the slide, and reflected light is measured after the reaction. This technology eliminates liquid reagent preparation, simplifies operation, and is widely adopted in point-of-care and small laboratory settings.

Automation Platforms

Automated chemistry analyzers incorporate sample barcode recognition, intelligent rerun and dilution logic, continuous cuvette washing, and reagent inventory management. High-throughput platforms coupled with laboratory automation tracks and middleware can process thousands of tests per hour with minimal operator intervention.

Applications

Clinical blood biochemical analysis supports a broad spectrum of healthcare activities, including:

  • Disease diagnosis and differential diagnosis, such as identifying hepatitis, pancreatitis, renal failure, and diabetic complications
  • Health screening and routine physical examination for early detection of asymptomatic metabolic abnormalities
  • Chronic disease management, including long-term monitoring of diabetes, dyslipidemia, chronic kidney disease, and gout
  • Therapeutic drug effect and safety monitoring, such as liver and renal function surveillance during medication
  • Preoperative evaluation and perioperative risk assessment
  • Critical care and emergency medicine, with rapid electrolyte and metabolic profiling guiding immediate intervention
  • Occupational health screening and toxicological exposure assessment
  • Clinical research, epidemiological studies, and pharmaceutical trial laboratory support

FAQ

Is fasting required before blood biochemical testing?

Fasting for 8–12 hours is recommended for lipid panels and fasting glucose to ensure accurate results, with water permitted. Other routine panels, such as electrolytes and liver enzymes, are less affected by recent meals, but consistent fasting conditions improve result comparability across serial measurements.

What is the typical turnaround time?

Routine biochemistry panels on automated analyzers are usually reported within 2–4 hours of specimen receipt. Emergency and stat samples, processed through rapid channels or point-of-care systems, can be completed within 30–60 minutes.

Why do hemolysis and lipemia affect results?

Hemolysis releases intracellular components such as potassium, LDH, and AST into the sample, causing falsely elevated values, while lipemia scatters light and interferes with photometric detection. Severely affected specimens should be rejected or processed with ultracentrifugation or hemolysis-adapted methods, and recollection is often recommended.

How are reference ranges established and interpreted?

Reference intervals are established from a healthy reference population, typically defined as the central 95% interval, and are specific to the analytical method, instrument, age, and sex. Results outside the interval should be interpreted in clinical context by a physician rather than used alone for diagnosis.

Do serum and plasma give identical results?

Most analytes show comparable values between serum and plasma, but plasma often yields slightly lower total protein and slightly higher results for some analytes released during clotting. Each laboratory validates its reference ranges for the specific specimen type used, and consistency in specimen type is important for longitudinal monitoring.